Tianjin Tasly Sants Pharmaceutical

Tianjin Tasly Sants Pharmaceutical is a core subsidiary of the Tasly Pharmaceutical Group, specializing in the research, development, and high-standard manufacturing of chemical drugs. Based in Tianjin, China, the company is a key driver of Tasly's internationalization strategy, operating facilities that are compliant with US FDA and EU GMP standards. Its product portfolio primarily consists of high-quality generic medications across therapeutic areas such as cardiovascular disease, oncology, and central nervous system disorders. Tasly Sants is recognized for its ability to produce both active pharmaceutical ingredients (APIs) and finished dosage forms for global markets. The company's commitment to quality has enabled it to successfully launch products like Temozolomide and Amlodipine in highly regulated international jurisdictions.